Cargando…
Comparison of Longevity in Patients with Idiopathic Pulmonary Fibrosis Using Pirfenidone Versus Triple Therapy with Prednisolone, Azathioprine, and Acetylcysteine
BACKGROUND: The effect of the combination of prednisolone, azathioprine, and acetylcysteine for the treatment of Idiopathic pulmonary fibrosis (IPF) is minimal. We aimed to investigate the effect of these drugs in case of intolerance to new anti-fibrotic drugs. MATERIALS AND METHODS: This historical...
Autores principales: | Asl, Mobin Soleimanian, Motakef, Zahra, Behgam, Nazgol, Attaran, Soroush, Mirsadraee, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618587/ https://www.ncbi.nlm.nih.gov/pubmed/37920315 |
Ejemplares similares
-
Azathioprine/prednisolone: COVID-19 infection: case report
Publicado: (2020) -
Azathioprine/prednisolone: COVID-19 infection: case report
Publicado: (2020) -
Methylprednisolone/prednisolone/azathioprine: Various toxicities: case report
Publicado: (2021) -
Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015) -
Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
por: Yu, Wencheng, et al.
Publicado: (2016)